{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:08:23Z","timestamp":1790064503925,"version":"4.0.1"},"reference-count":68,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,4,8]]},"DOI":"10.3233\/jad-180940","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T17:20:31Z","timestamp":1553016031000},"page":"1243-1255","source":"Crossref","is-referenced-by-count":19,"title":["Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"68","author":[{"given":"Emmanuelle","family":"Boscher","sequence":"first","affiliation":[{"name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval, CHUL, Axe Neurosciences, Qu\u00e9bec, Canada"},{"name":"Facult\u00e9 de m\u00e9decine, D\u00e9partement de psychiatrie et de neurosciences, Universit\u00e9 Laval, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FREX Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Husson","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Quenez","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Laquerri\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Pathology, Normandie Univ, UNIROUEN, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Marguet","sequence":"additional","affiliation":[{"name":"Department of Pathology, Normandie Univ, UNIROUEN, Rouen University Hospital, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Cassinari","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wallon","sequence":"additional","affiliation":[{"name":"Department of Neurology and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Martinaud","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNICAEN, EPHE, INSERM, U1077, CHU de Caen, Neuropsychologie et Imagerie de la M\u00e9moire Humaine, Caen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Charbonnier","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Nicolas","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Deleuze","sequence":"additional","affiliation":[{"name":"Centre National de recherche en G\u00e9nomique Humaine, Institut de G\u00e9nomique, CEA, Evry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Boland","sequence":"additional","affiliation":[{"name":"Centre National de recherche en G\u00e9nomique Humaine, Institut de G\u00e9nomique, CEA, Evry, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lathrop","sequence":"additional","affiliation":[{"name":"McGill University and G\u00e9nome Qu\u00e9bec Innovation Centre, Montr\u00e9al, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Fr\u00e9bourg","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Campion","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien S.","family":"H\u00e9bert","sequence":"additional","affiliation":[{"name":"Centre de recherche du CHU de Qu\u00e9bec-Universit\u00e9 Laval, CHUL, Axe Neurosciences, Qu\u00e9bec, Canada"},{"name":"Facult\u00e9 de m\u00e9decine, D\u00e9partement de psychiatrie et de neurosciences, Universit\u00e9 Laval, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rovelet-Lecrux","sequence":"additional","affiliation":[{"name":"Department of Genetics and CNR-MAJ, Normandie Univ, UNIROUEN, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180940_ref1","doi-asserted-by":"crossref","unstructured":"(2016) 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 12, 459\u2013509.","DOI":"10.1016\/j.jalz.2016.03.001"},{"key":"10.3233\/JAD-180940_ref2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-p peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","author":"Gatz","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-180940_ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneurol.2011.221","article-title":"Autosomal recessive causes likely in early-onset Alzheimer disease","volume":"69","author":"Wingo","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-180940_ref5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1172\/JCI24761","article-title":"The genetic epidemiology of neurodegenerative disease","volume":"115","author":"Bertram","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-180940_ref6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","article-title":"Early-onset autosomal dominant Alzheimer disease: Preva-lence, genetic heterogeneity, and mutation spectrum","volume":"65","author":"Campion","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-180940_ref7","doi-asserted-by":"crossref","first-page":"220.e1","DOI":"10.1016\/j.neurobiolaging.2017.07.001","article-title":"Contribution to Alzheimer\u2019s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls","volume":"59","author":"Bellenguez","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180940_ref8","doi-asserted-by":"crossref","unstructured":"(2018) 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 14, 367\u2013429.","DOI":"10.1016\/j.jalz.2018.02.001"},{"key":"10.3233\/JAD-180940_ref9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygeno.2013.04.004","article-title":"Increased CNV-Region deletions in mild cognitive impairment (MCI) and Alzheimer\u2019s disease (AD) subjects in the ADNI sample","volume":"102","author":"Guffanti","year":"2013","journal-title":"Genomics"},{"key":"10.3233\/JAD-180940_ref10","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/molbev\/msx183","article-title":"Inference of causative genes for Alzheimer\u2019s disease due to dosage imbalance","volume":"34","author":"Sekine","year":"2017","journal-title":"Mol Biol Evol"},{"key":"10.3233\/JAD-180940_ref11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng1718","article-title":"APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy","volume":"38","author":"Rovelet-Lecrux","year":"2006","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180940_ref12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"17","author":"Brouwers","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-180940_ref13","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1038\/tp.2012.119","article-title":"Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer\u2019s disease","volume":"2","author":"Li","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-180940_ref14","doi-asserted-by":"crossref","unstructured":"Shaw CA , Li Y , Wiszniewska J , Chasse S , Zaidi SNY , Jin W , Dawson B , Wilhelmsen K , Lupski JR , Belmont JW , Doody RS , Szigeti K (2011) Olfactory copy number association with age at onset of Alzheimer disease. Neurology 76,13021309.","DOI":"10.1212\/WNL.0b013e3182166df5"},{"key":"10.3233\/JAD-180940_ref15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-2012-121285","article-title":"Genome-wide scan for copy number variation association with age at onset of Alzheimer\u2019s disease.","volume":"33","author":"Szigeti","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.3233\/JAD-180940_ref17","first-page":"1","article-title":"MicroRNAs and Alzheimer\u2019s disease mouse models: Current insights and future research avenues","author":"Delay","year":"2011","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphys.2015.00040","article-title":"The emerging role of microRNAs in Alzheimer\u2019s disease","volume":"6","author":"Femminella","year":"2015","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-180940_ref19","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/ -secretase expression","volume":"105","author":"H\u00e9bert","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JAD-180940_ref20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biopsych.2014.05.011","article-title":"Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets","volume":"77","author":"Warnica","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-180940_ref21","doi-asserted-by":"crossref","first-page":"e56781","DOI":"10.1371\/journal.pone.0056781","article-title":"Insights on the functional impact of microRNAspresent in autism-associated copy number variants","volume":"8","author":"Vaishnavi","year":"2013","journal-title":"PloS One"},{"key":"10.3233\/JAD-180940_ref22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/1471-2164-14-544","article-title":"miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability","volume":"14","author":"Qiao","year":"2013","journal-title":"BMC Genomics"},{"issue":"17q21.31","key":"10.3233\/JAD-180940_ref23","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/mp.2016.226","article-title":"duplication causes prominent tau-related dementia with increased MAPT expression","volume":"22","author":"Le Guennec","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-180940_ref24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/mp.2015.121","article-title":"SORL1 rare variants: A major risk factor for familial early-onset Alzheimer\u2019s disease","volume":"21","author":"Nicolas","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-180940_ref25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/ejhg.2015.173","article-title":"Screening of dementia genes by whole-exome 0sequencing in early-onset Alzheimer disease","volume":"24","author":"Nicolas","year":"2016","journal-title":"Input and lessons. Eur J Hum Genet"},{"key":"10.3233\/JAD-180940_ref26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"AA. Genome Res"},{"key":"10.3233\/JAD-180940_ref27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.3233\/JAD-180940_ref28","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1093\/nar\/gku345","article-title":"CANOES: Detecting rare copy number variants from whole exome sequencing data","volume":"42","author":"Backenroth","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JAD-180940_ref29","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/nprot.2010.116","article-title":"Data quality control in genetic case-control association studies","volume":"5","author":"Anderson","year":"2010","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-180940_ref30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: Rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"GigaScience"},{"key":"10.3233\/JAD-180940_ref31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ajhg.2012.09.004","article-title":"Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data","volume":"91","author":"Jun","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-180940_ref32","first-page":"2760","article-title":"Detection of exon deletions and duplicationsof the mismatch repair genes in hereditary nonpolyposis col-orectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments","volume":"60","author":"Charbonnier","year":"2000","journal-title":"Cancer Res"},{"key":"10.3233\/JAD-180940_ref33","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1093\/hmg\/ddr330","article-title":"MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy","volume":"20","author":"Smith","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-180940_ref34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","article-title":"ImageJ2: ImageJ for the next generation of scientific image data","volume":"18","author":"Rueden","year":"2017","journal-title":"BMC Bioinformat-ics"},{"key":"10.3233\/JAD-180940_ref35","doi-asserted-by":"crossref","first-page":"335348","DOI":"10.3233\/JAD-122350","article-title":"A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer\u2019s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls","volume":"35","author":"H\u00e9bert","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-180940_ref37","doi-asserted-by":"crossref","unstructured":"GTEx Consortium (2013) The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580\u2013585.","DOI":"10.1038\/ng.2653"},{"key":"10.3233\/JAD-180940_ref38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","article-title":"Alterations of the microRNA network cause neurodegenerative disease.","volume":"32","author":"H\u00e9bert","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-180940_ref39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","article-title":"Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways","volume":"14","author":"Cogswell","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref40","first-page":"501","article-title":"MicroRNA-138 is a potential regulator of memory performance in humans","volume":"8","author":"Schr\u00f6der","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"10.3233\/JAD-180940_ref41","doi-asserted-by":"crossref","first-page":"861871","DOI":"10.1038\/mp.2016.38","article-title":"Alzheimer disease: Modeling an A\u00df-centered biological network","volume":"21","author":"Campion","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-180940_ref42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1158\/1541-7786.MCR-15-0299","article-title":"miR-138-mediated regulation of KINDLIN-2 expression modulates sensitivity to chemotherapeutics.","volume":"14","author":"Sossey-Alaoui","year":"2016","journal-title":"Mol Cancer Res"},{"key":"10.3233\/JAD-180940_ref43","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00401-016-1652-z","article-title":"Genome-wide, high-content siRNA screening identifies the Alzheimer\u2019s genetic riskfactor FERMT2 as a major modulator of APP metabolism","volume":"133","author":"Chapuis","year":"2017","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-180940_ref44","first-page":"1452","article-title":"European Alzheimer\u2019s Disease Initiative (EADI); Genetic and Environmental Risk in Alzheimer\u2019s Disease; Alzheimer\u2019s Disease Genetic Consortium","volume":"45","author":"Lambert","year":"2013","journal-title":"Cohorts for Heart and Aging Research in Genomic Epidemiology"},{"key":"10.3233\/JAD-180940_ref45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180940_ref46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.febslet.2015.02.001","article-title":"MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha","volume":"589","author":"Wang","year":"2015","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-180940_ref47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/srep00480","article-title":"Hypothermia-induced hyperphosphorylation: A new model to study tau kinase inhibitors","volume":"2","author":"Bretteville","year":"2012","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-180940_ref48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1326-2-12","article-title":"Tau phosphoryla-tion by GSK-3 \u00df promotes tangle-like filament morphology","volume":"2","author":"Rankin","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-180940_ref49","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.","volume":"7","author":"Frame","year":"2001","journal-title":"Mol Cell"},{"key":"10.3233\/JAD-180940_ref50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3 \u00df-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-180940_ref51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mi.8.5.8","article-title":"Looking at lithium: Molecular moods and complex behaviour","volume":"8","author":"Beaulieu","year":"2008","journal-title":"Mol Interv"},{"key":"10.3233\/JAD-180940_ref52","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16at13q14in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl AcadSciUSA"},{"key":"10.3233\/JAD-180940_ref53","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/ng.3092","article-title":"Refining analyses of copy number variation identifies specific genes associated with developmental delay.","volume":"46","author":"Coe","year":"2014","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-180940_ref54","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ejhg.2011.225","article-title":"A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease","volume":"20","author":"Rovelet-Lecrux","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-180940_ref55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/mp.2013.77","article-title":"Rare autosomal copy number variations in early-onset familial Alzheimer\u2019s disease","volume":"19","author":"Hooli","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-180940_ref56","doi-asserted-by":"crossref","first-page":"561-5","DOI":"10.3233\/JAD-2011-111148","article-title":"Amyloid- \u00df protein precursor gene expression in Alzheimer\u2019s disease and other conditions","volume":"28","author":"Pottier","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180940_ref57","doi-asserted-by":"crossref","first-page":"e0139233","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma Eeosomal miRNAs in persons with and without Alzheimer disease: Altered expression and prospects for biomarkers","volume":"10","author":"Lugli","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180940_ref58","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/emmm.201201974","article-title":"Alteration of the microRNA network during the progression of Alzheimer\u2019s disease","volume":"5","author":"Lau","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-180940_ref59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/embor.2008.202","article-title":"Kindlins: Essential regulators of integrin signalling and cell-matrix adhesion","volume":"9","author":"Larjava","year":"2008","journal-title":"EMBO Rep"},{"key":"10.3233\/JAD-180940_ref60","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.1073\/pnas.1703064114","article-title":"Structural basis of kindlin-mediated integrin recognition and activation","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/JAD-180940_ref61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-016-0186-x","article-title":"miRNA-dependent target regulation: Functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer\u2019s disease","volume":"8","author":"Delay","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180940_ref62","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/hmg\/ddt478","article-title":"Functional screening in Drosophila identifies Alzheimer\u2019s disease susceptibility genes and implicates Tau-mediated mechanisms","volume":"23","author":"Shulman","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-180940_ref63","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s13277-015-3044-8","article-title":"Kindlin-2 inhibited the growth and migration of colorectal cancer cells","volume":"36","author":"Ren","year":"2015","journal-title":"Tumour Biol"},{"key":"10.3233\/JAD-180940_ref64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2013.10.062","article-title":"Transcriptome-wide discovery of microRNA binding sites in human brain","volume":"81","author":"Boudreau","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-180940_ref65","doi-asserted-by":"crossref","first-page":"44104418","DOI":"10.1128\/MCB.00930-12","article-title":"Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-\u00df precursor protein","volume":"32","author":"Parr","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.3233\/JAD-180940_ref66","first-page":"10","article-title":"The role of microRNA in the pathogenesis and diagnosis of neurodegenerative diseases","volume":"1","author":"Prendecki","year":"2014","journal-title":"Austin Alzheimers J Park Dis"},{"key":"10.3233\/JAD-180940_ref67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: Discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect Clin Res"},{"key":"10.3233\/JAD-180940_ref68","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:17Z","timestamp":1777370957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/JAD-180940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":68,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180940","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]}}}